|
TIDMAMP
RNS Number : 2246Y
Amphion Innovations PLC
28 February 2012
Amphion Innovations plc
Directors' Dealings Directors Receive Shares in Lieu of Fees
London and New York, 28 February 2012- Amphion Innovations plc (the "Company") (LSE: AMP), the developer of medical and technology businesses, announces that the Company has today issued 160,486 ordinary shares, representing 0.12% of the enlarged issued share capital, to certain of its Board members as their directors' fees for the fourth quarter to 31 December 2011, priced at 4.98p, being the average of the closing mid-market price for the five days leading up to the market close on 23 February 2012. Following this issue, the directors' shareholdings in the Company are as follows:
Director Number of New Shares Total Shareholding Percentage of voting rights
R. James Macaleer 110,486 23,537,733 17.43%
Gerard Moufflet 50,000 550,000 0.41%
Director, Anthony Henfrey waived his fees for the fourth quarter of 2011.
Admission of the 160,486 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 5 March 2012. Following this allotment the total issued share capital of the Company will increase to 135,009,038 ordinary shares with each share holding one voting right.
For further information please contact:
Amphion Innovations
Charlie Morgan:
+1 212 210 6224
Seymour Pierce Limited
Freddy Crossley/ Mark Percy
+44 020 7107 8300
Cardew Group
Tim Robertson
+44 020 7930 0777
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBIGDDDDDBGDR
| 
